PHASE 3 RANDOMIZED TRIAL OF MOMELOTINIB VERSUS BEST AVAILABLE THERAPY IN PATIENTS WITH MYELOFIBROSIS PREVIOUSLY TREATED WITH RUXOLITINIB: RESULTS OF THE SIMPLIFY-2 STUDY

被引：0

作者：

Verstovsek, S. ^{[1
]}

Vannucchi, A. M. ^{[2
]}

Platzbecker, U. ^{[3
]}

Cervantes, F. ^{[4
]}

Gupta, V. ^{[5
]}

Lavie, D. ^{[6
]}

Passamonti, F. ^{[7
]}

Winton, E. F. ^{[8
]}

Dong, H. ^{[9
]}

Kawashima, J. ^{[9
]}

Maltzman, J. D. ^{[9
]}

Kiladjian, J-J. ^{[10
,11
]}

Harrison, C. N. ^{[12
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Univ Florence, Florence, Italy

[3] Tech Univ, Med Fak Carl Gustav Carus, Dresden, Germany

[4] Univ Barcelona, Hosp Clin, Barcelona, Spain

[5] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada

[6] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel

[7] Univ Insubria, Varese, Italy

[8] Emory Univ, Sch Med, Atlanta, GA USA

[9] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[10] St Louis Hosp, AP HP, Paris, France

[11] Paris Diderot Univ, Paris, France

[12] Guys & St Thomas NHS Fdn Trust, London, England

来源：

HAEMATOLOGICA | 2017年 / 102卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

S786

引用

页码：320 / 321

页数：2

共 50 条

[21] MOMENTUM: Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated With a JAK Inhibitor
Mesa, Ruben
Gerds, Aaron
Vannucchi, Alessandro
Al-Ali, Haifa Kathrin
Lavie, David
Kuykendall, Andrew
Grosicki, Sebastian
Iurlo, Alessandra
Goh, Yeow Tee
Lazaroiu, Mihaela
Egyed, Miklos
Fox, Maria Laura
McLornan, Donal
Perkins, Andrew
Yoon, Sung-Soo
Gupta, Vikas
Kiladjian, Jean-Jacques
Donahue, Rafe
Kawashima, Jun
Verstovsek, Srdan
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S339 - S340
[22] Phase III randomized, double-blind, active-controlled study of momelotinib versus ruxolitinib in patients with myelofibrosis.
Winton, Elliott F.
Devos, Timothy
Oh, Stephen T.
Platzbecker, Uwe
Wadleigh, Martha
Jun, Susie
Lee, Peter
Deng, Wei
Gupta, Vikas
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[23] MOMENTUM: Phase 3 randomized study of momelotinib (MMB) versus danazol (DAN) in symptomatic and anemic myelofibrosis (MF) patients previously treated with a JAK inhibitor.
Mesa, Ruben A.
Gerds, Aaron Thomas
Vannucchi, Alessandro
Al-Ali, Haifa Kathrin
Lavie, David
Kuykendall, Andrew T.
Grosicki, Sebastian
Iurlo, Alessandra
Goh, Yeow Tee
Lazaroiu, Mihaela Cornelia
Egyed, Miklos
Fox, Maria Laura
McLornan, Donal P.
Perkins, Andrew
Yoon, Sung-Soo
Gupta, Vikas
Kiladjian, Jean-Jacques
Donahue, Rafe
Kawashima, Jun
Verstovsek, Srdan
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[24] A Phase 3, Open-Label, Randomized Study Evaluating the Efficacy and Safety of Navitoclax Plus Ruxolitinib Versus Best Available Therapy in Patients with Relapsed/Refractory Myelofibrosis (TRANSFORM-2)
Dilley, Kimberley
Harb, Jason
Jalaluddin, Muhammad
Hutti, Jessica E.
Potluri, Jalaja
BLOOD, 2020, 136
[25] Ruxolitinib Versus Best Available Therapy for PV Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial
Harrison, Claire
Nangalia, Jyoti
Boucher, Rebecca H.
Jackson, Aimee
Yap, Christina
O'Sullivan, Jennifer
Fox, Sonia
Ailts, Isaak
Dueck, Amylou C.
Geyer, Holly L.
Mesa, Ruben
Dunn, William
Nadezhdin, Eugene
Curto-Garcia, Natalia
Green, Anna
Wilkins, Bridget
Coppell, Jason
Laurie, John
Garg, Mamta
Ewing, Joanne
Knapper, Steve
Crowe, Josephine
Koutsavlis, Ioannis
Godfrey, Anna L.
Arami, Siamak
Drummond, Mark W.
Byrne, Jennifer
Clark, Fiona J.
Mead-Harvey, Carolyn
Baxter, Joanna E.
McMullin, Mary Frances
Mead, Adam J.
BLOOD, 2022, 140 : 1781 - 1783
[26] PACRITINIB (PAC) VS BEST AVAILABLE THERAPY (BAT), IN PATIENTS WITH MYELOFIBROSIS (MF) AND BASELINE (BL) THROMBOCYTOPENIA: FOCUS ON RUXOLITINIB (RUX)-TREATED PATIENTS IN THE PHASE 3 PERSIST-2 TRIAL
Harrison, C.
Mascarenhas, J.
Hoffman, R.
Talpaz, M.
Gerds, A. T.
Stein, B.
Gupta, V.
Szoke, A.
Drummond, M.
Pristupa, A.
Granston, T.
Daly, R.
Al-Fayoumi, S.
Callahan, J. A.
Singer, J. W.
Gotlib, J.
Jamieson, C.
Mesa, R.
Verstovsek, S.
HAEMATOLOGICA, 2017, 102 : 280 - 281
[27] Updated Results from the Momentum Phase 3 Study of Momelotinib (MMB) Versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor
Gerds, Aaron T.
Mesa, Ruben
Vannucchi, Alessandro M.
Al-Ali, Haifa Kathrin
Lavie, David
Kuykendall, Andrew
Grosicki, Sebastian
Iurlo, Alessandra
Goh, Yeow Tee
Lazaroiu, Mihaela
Egyed, Miklos
Fox, Maria Laura
McLornan, Donal P.
Perkins, Andrew Charles
Yoon, Sung-Soo
Gupta, Vikas
Kiladjian, Jean-Jacques
Donahue, Rafe
Kawashima, Jun
Verstovsek, Srdan
BLOOD, 2022, 140 : 1514 - 1517
[28] Overall Survival with Momelotinib Vs Best Available Therapy in Patients with Ruxolitinib-Experienced Myelofibrosis: A Matching-Adjusted Indirect Comparison
Palandri, Francesca
Kapetanakis, Venediktos
Dobi, Balazs
Branzanti, Filippo
Ellis, Catherine
Ballew, Nick
Liu, Tom
Phiri, Kelesitse
Sen Nikitas, Fulya
Biasi, Melania
Zhang, Shiyuan
Patnaik, Dwaipayan
BLOOD, 2024, 144 : 3187 - 3188
[29] Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial
Harrison, Claire N.
Nangalia, Jyoti
Boucher, Rebecca
Jackson, Aimee
Yap, Christina
O'Sullivan, Jennifer
Fox, Sonia
Ailts, Isaak
Dueck, Amylou C.
Geyer, Holly L.
Mesa, Ruben A.
Dunn, William G.
Nadezhdin, Eugene
Curto-Garcia, Natalia
Green, Anna
Wilkins, Bridget
Coppell, Jason
Laurie, John
Garg, Mamta
Ewing, Joanne
Knapper, Steven
Crowe, Josephine
Chen, Frederick
Koutsavlis, Ioannis
Godfrey, Anna
Arami, Siamak
Drummond, Mark
Byrne, Jennifer
Clark, Fiona
Mead-Harvey, Carolyn
Baxter, Elizabeth Joanna
McMullin, Mary Frances
Mead, Adam J.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (19) : 3534 - +
[30] Transfusion-Related Cost and Time Burden Offsets in Patients With Myelofibrosis Treated With Momelotinib vs Best Available Therapy
Masarova, Lucia
Liu, Tom
Rao, Sumati
Fillbrunn, Mirko
Li, Weilong
Sajeev, Gautam
Gorsch, Boris
Signorovitch, James
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S402 - S402

← 1 2 3 4 5 →